arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Strata Critical Medical, Inc.

SRTA
$5.38 ▼ -0.12 (-2.18%) at close
Healthcare ·Services-Health Services ·USServices-Health Services
27 Visible periods
28 Metrics
Peer-ranked Benchmarks
Price Chart
49
Health
Weak
Bullish
auto_awesome

Analytical Summary

Strata Critical Medical, Inc. shows strong fundamentals with top-quartile Return on Common Equity (%) and Profit Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $463.8M
Dividend Yield
Revenue Growth 2.4%
Op. Margin -7.5%
ROIC -1.9%
FCF / Share $0.04
Trailing P/E
Price / Book 1.7x
FCF Yield 0.7%
Debt / Equity
info Valuation on last close. End-of-day price, Sep 23, 2026.

27-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$72.51M
↑ +2.4%
Net Income Profit after all expenses
$-10.52M
↓ -181.0%
Operating Margin Operating profit as % of sales
-7.5%
↓ -69.0% 14th
FCF / Share Free cash flow per share
$0.04
↑ +344.5%
trending_up

Bullish Indicators

  • Profit Margin (%)Profit Margin (%) is in the top quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile

Health Breakdown

Profitability
35
Returns
80
Cash Quality
8

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 7 years · 27 quarters